Literature DB >> 25583180

The pain of pain: challenges of animal behavior models.

James E Barrett1.   

Abstract

Berend Olivier has had a long-standing interest in the utility of animal models for a wide variety of therapeutic indications. His work has spanned multiple types of models, blending ethological, or species typical and naturalistic behaviors, along with methodologies based on learned behavior. He has consistently done so, from an analytical as well as predictive perspective, and has made multiple contributions while working in both the pharmaceutical industry and within an academic institution. Although focused primarily on psychiatric disorders, Berend has conducted research in the area of pain in humans and in animals, demonstrating an expansive appreciation for the breadth, scope and significance of the science and applications of the discipline of pharmacology to these diverse areas. This review focuses on the use of animal models in pain research from the perspective of the long-standing deficiencies in the development of therapeutics in this area and from a preclinical perspective where the translational weaknesses have been quite problematic. The challenges confronting animal models of pain, however, are not unique to this area of research, as they cut across several therapeutic areas. Despite the deficiencies, failures and concerns, existing animal models of pain continue to be of widespread use and are essential to progress in pain research as well as in other areas. Although not focusing on specific animal models of pain, this paper seeks to examine general issues facing the use of these models. It does so by exploring alternative approaches which capture recent developments, which build upon principles and concepts we have learned from Berend's contributions, and which provide the prospect of helping to address the absence of novel therapeutics in this area.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Berend Olivier; Biomarkers; Pain; Sigma1; Translational research

Mesh:

Substances:

Year:  2015        PMID: 25583180     DOI: 10.1016/j.ejphar.2014.11.046

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Sigma-1 receptor and inflammatory pain.

Authors:  Georgia Gris; Enrique José Cobos; Daniel Zamanillo; Enrique Portillo-Salido
Journal:  Inflamm Res       Date:  2015-04-23       Impact factor: 4.575

2.  Developing Improved Translational Models of Pain: A Role for the Behavioral Scientist.

Authors:  Sarah L Withey; David R Maguire; Brian D Kangas
Journal:  Perspect Behav Sci       Date:  2020-01-03

Review 3.  The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.

Authors:  Terence J Coderre; André Laferrière
Journal:  J Neural Transm (Vienna)       Date:  2019-11-18       Impact factor: 3.575

Review 4.  Preclinical Pain Research: Can We Do Better?

Authors:  J David Clark
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

5.  Designing Brains for Pain: Human to Mollusc.

Authors:  Brian Key; Deborah Brown
Journal:  Front Physiol       Date:  2018-08-02       Impact factor: 4.566

Review 6.  Modeling Complex Orthopedic Trauma in Rodents: Bone, Muscle and Nerve Injury and Healing.

Authors:  Huaishuang Shen; Aysha M Gardner; Juhee Vyas; Ryosuke Ishida; Vivianne L Tawfik
Journal:  Front Pharmacol       Date:  2021-02-01       Impact factor: 5.810

Review 7.  Chronic Orofacial Pain: Models, Mechanisms, and Genetic and Related Environmental Influences.

Authors:  Barry J Sessle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  Effect of sex in the MRMT-1 model of cancer-induced bone pain.

Authors:  Sarah Falk; Tamara Al-Dihaissy; Laura Mezzanotte; Anne-Marie Heegaard
Journal:  F1000Res       Date:  2015-07-31

9.  Antinociceptive Activity of Chemical Components of Essential Oils That Involves Docking Studies: A Review.

Authors:  Davidson Barbosa Assis; Humberto de Carvalho Aragão Neto; Diogo Vilar da Fonsêca; Humberto Hugo Nunes de Andrade; Renan Marinho Braga; Nader Badr; Mayara Dos Santos Maia; Ricardo Dias Castro; Luciana Scotti; Marcus Tullius Scotti; Reinaldo Nóbrega de Almeida
Journal:  Front Pharmacol       Date:  2020-05-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.